Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gil Block, MD, PhD
Neuraltus Pharmaceuticals, Inc.
Study Director - Robert G. Miller, MD
California Pacific Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Montreal Neurological Institute
Montreal, Quebec, Canada
- St. Joseph'S Hospital and Medical Center - Barrow Neurology Clinics
Phoenix, Arizona, United States
- Mayo Clinic Arizona
Scottsdale, Arizona, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- University of California, Irvine, Department of Neurology
Orange, California, United States
- Forbes Norris Mda/als Research Center, Cpmc
San Francisco, California, United States
- Mayo Clinic Florida
Jacksonville, Florida, United States
- University of Miami Miller School of Medicine
Miami, Florida, United States
- Emory University, Department of Neurology
Atlanta, Georgia, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- University of Kentucky, Albert B. Chandler Medical Center
Lexington, Kentucky, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Clinical & Translational Science Institute, University of Minnesota
Minneapolis, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Columbia University Medical Center
New York, New York, United States
- Carolinas Medical Center, Neurosciences Instutite-Neurology
Charlotte, North Carolina, United States
- Duke Neurological Disorders Clinic at Morreene Road
Durham, North Carolina, United States
- Cleveland Clinic Foundation-Cleveland Clinic Hospital
Cleveland, Ohio, United States
- the Ohio State University Wexner Medical Center
Columbus, Ohio, United States
- Providence Brain & Spine Institute, Als Center
Portland, Oregon, United States
- Houston Methodist Neurological Institute
Houston, Texas, United States
- University of Texas Health Sciences Center San Antonio
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Aug 2016
- Primary completion
- 12 Dec 2017
- Completion
- 12 Dec 2017
- Last update posted
- 7 May 2018
- Registered enrollment
- 138
- Registry id
- NCT02794857
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.